Growth Metrics

Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021)

Treace Medical Concepts posted quarterly Preferred Shares of $7.9 million for Q1 2021, little changed on a QoQ basis from $7.9 million in Q4 2020.

Treace Medical Concepts (TMCI) has 2 years of Preferred Shares data on file, last reported at $7.9 million in Q1 2021.

  • For the quarter ending Q1 2021, Preferred Shares changed N/A year-over-year to $7.9 million; the trailing twelve-month figure through Mar 2021 stood at $7.9 million (changed N/A YoY), and the FY2020 full-year result was $7.9 million, changed N/A from the prior year.
  • Preferred Shares for Q1 2021 stood at $7.9 million, roughly flat from $7.9 million in the prior quarter.
  • Across five years, Preferred Shares topped out at $7.9 million in Q4 2020 and bottomed at $7.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Treace Medical Concepts 234.79 Mn 182.94 Mn 37.41 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2021 7.94 Mn
Dec 31, 2020 7.94 Mn